First Wave BioPharma (NASDAQ:FWBI) Given New $10.00 Price Target at HC Wainwright

First Wave BioPharma (NASDAQ:FWBI – Get Rating) had its price target cut by HC Wainwright from $14.00 to $10.00 in a report published on Monday morning, The Fly reports. HC Wainwright also issued estimates for First Wave BioPharma’s Q2 2023 earnings at ($1.00) EPS, Q3 2023 earnings at ($0.67) EPS, Q4 2023 earnings at ($0.55) […]

Related Keywords

,First Wave Biopharma Company Profile ,Citigroup Inc ,First Wave Biopharma Inc ,Armistice Capital ,First Wave Biopharma ,Get Rating ,Wave Biopharma ,Street Corp ,First Wave Biopharma Daily ,Nasdaq Fwbi ,Fwbi ,Medical ,Lower Price Target ,Hc Wainwright ,